You are here: Industry Insights > Pharma in China > Chinese-produced new drugs to be marketed soon in 2019

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Chinese-produced new drugs to be marketed soon in 2019

PharmaSources/CaicaiJanuary 21, 2019

Tag: new drugs , 2019 , Chinese-produced Drug

Favorites

Chinese-produced new drugs to be marketed soon in 2019:

Chinese-produced new drugs to be marketed soon in 2019

Pharmaceutical product name	Mechanism of action	Registration classification	Company
Polyethylene Glycol Loxenatide Injection	Long-acting GLP-1 receptor agonist	Chemical drug 1	Hansoh
Utidelone Injection	Non-taxane tubulin polymerization-resistant antitumor drug	Chemical drug 1	Biostar
Camrelizumab for Injection	Anti-PD-1 antibody	Biological product for treatment1	Jiangsu Suncadia
Avitinib Maleate Capsules	Third-generation EGFR TKI	Chemical drug 1	ACEA Pharma
Fumaritidine Mesylate Tablets	Second-generation Bcr-Abl TKI	Chemical drug 1	Hansoh
Zanubrutinib Capsules	BTK inhibitor	Chemical drug 1	BeiGene
Tislelizumab Injection	Anti-PD-1 antibody	Biological product for treatment 1	BeiGene, Celgene, Boehringer Ingelheim
Sodium Oligomannurarate Capsules	Marine oligosaccharide molecule	Chemical drug 1	Chinese Academy of Sciences and GreenValley

(Sorted out based on public data. Any supplementation will be much appreciated. *Jiangsu Suncadia is a subsidiary of Hengrui Medicine)

About the Author:

Caicai, a Master of Pharmacy from Shanghai Jiaotong University, used to work in the Institute of Science and Technical Information. Currently as a practitioner in the drug surveillance system, she is good at interpreting industry regulations, pharmaceutical research developments, etc.

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

Previous:Preparing samples of cannabis plant for THC/CBD analysis

Next:Chinese-produced New Drugs Approved for Marketing in 2018

China's Innovative Drugs Hunt for Billion Dollar Molecule

XiaobinDecember 20, 2024

The Central Economic Work Conference in 2023 emphasized the need to promote industrial innovation through, especially by fostering new industries, new models, and new growth engines and developing new forms of productive forces.

Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global

YiDecember 20, 2024

New Pathways for Innovation and Transformation of Local Pharmaceutical Companies

XiaobinDecember 20, 2024

Chinese-produced new drugs to be marketed soon in 2019 | Pharmasources.com

Established Pharmaceutical Company Makes a High-profile Entrance with "Unlimited" R&D Investment, Signaling an Imminent Explosion in This Emerging Field

xiaobinDecember 20, 2024

Recently, Northeast Pharm announced its plan to acquire a 70% stock equity in Dingcheng Taiyuan for a total cash consideration of approximately RMB 187 million, thereby obtaining controlling stake in the company.

Chinese-produced new drugs to be marketed soon in 2019

About the Author:

Related News

China's Innovative Drugs Hunt for Billion Dollar Molecule

Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global

New Pathways for Innovation and Transformation of Local Pharmaceutical Companies

Established Pharmaceutical Company Makes a High-profile Entrance with "Unlimited" R&D Investment, Signaling an Imminent Explosion in This Emerging Field

You may like
More>>

Chinese-produced new drugs to be marketed soon in 2019

About the Author:

Related News

China's Innovative Drugs Hunt for Billion Dollar Molecule

Leading the Development of Bispecific ADCs, Multiple Chinese New Drugs Go Global

New Pathways for Innovation and Transformation of Local Pharmaceutical Companies

Established Pharmaceutical Company Makes a High-profile Entrance with "Unlimited" R&D Investment, Signaling an Imminent Explosion in This Emerging Field

You may likeMore>>

You may like
More>>